ISO. Nanotechnologies—Considerations for the development of chemical nomenclature for selected nano‐objects (ISO/TR 14786:2014); 2014:1–38.
ANSI. Talking the Talk: Standardizing the Language of Nanotechnology. Nanotechnology Law Report (Nano‐Law‐Report‐WG1_08_08); 2008, August: 1–4.
EU. Commission recommendation of 18 October 2011 on the definition of nanomaterial. Official Journal of the European Union. European Union. Available at: http://eur‐lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2011:275:0038:0040:EN:PDF. 2011.
Monteiro‐Riviere, NA, Tran, CL. Nanotoxicology: Progress Toward Nanomedicine. 2nd ed. Boca Raton, FL: Taylor %26 Francis Group; 2014.
Lee, J, Mahendra, S, Alvarez, PJ. Nanomaterials in the construction industry: a review of their applications and environmental health and safety considerations. ACS Nano 2010, 4:3580–3590.
Arvizo, RR, Bhattacharyya, S, Kudgus, RA, Giri, K, Bhattacharya, R, Mukherjee, P. Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future. Chem Soc Rev 2012, 41:2943–2970.
Khlebtsov, N, Dykman, L. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem Soc Rev 2011, 40:1647–1671.
Samberg, ME, Monteiro‐Riviere, NA. Silver nanoparticles in biomedical applications. In: Monteiro‐Riviere, NA, Tran, CL, eds. Nanotoxicology: Progress Toward Nanomedicine. Boca Raton, FL: CRC Press; 2014 Chapter 22, 405–421.
Samberg, ME, Orndorff, PE, Monteiro‐Riviere, NA. Antibacterial efficacy of silver nanoparticles of different sizes, surface conditions and synthesis methods. Nanotoxicology 2011, 5:244–253.
Mody, VV, Siwale, R, Singh, A, Mody, HR. Introduction to metallic nanoparticles. J Pharm Bioallied Sci 2010, 2:282–289.
Laurent, S, Forge, D, Port, M, Roch, A, Robic, C, Vander Elst, L, Muller, RN. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 2008, 108:2064–2110.
Monteiro‐Riviere, NA, Wiench, K, Landsiedel, R, Schulte, S, Inman, AO, Riviere, JE. Safety evaluation of sunscreen formulations containing titanium dioxide and zinc oxide nanoparticles in UVB sunburned skin: an in vitro and in vivo study. Toxicol Sci 2011, 123:264–280.
Riviere, JE. Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009, 1:26–34.
Li, SD, Huang, L. Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm 2008, 5:496–504.
Sadauskas, E, Wallin, H, Stoltenberg, M, Vogel, U, Doering, P, Larsen, A, Danscher, G. Kupffer cells are central in the removal of nanoparticles from the organism. Part Fibre Toxicol 2007, 4:10.
Kattumuri, V, Katti, K, Bhaskaran, S, Boote, EJ, Casteel, SW, Fent, GM, Robertson, DJ, Chandrasekhar, M, Kannan, R, Katti, KV. Gum arabic as a phytochemical construct for the stabilization of gold nanoparticles: in vivo pharmacokinetics and X‐ray‐contrast‐imaging studies. Small 2007, 3:333–341.
Zhang, G, Yang, Z, Lu, W, Zhang, R, Huang, Q, Tian, M, Li, L, Liang, D, Li, C. Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol‐coated gold nanoparticles in tumor‐xenografted mice. Biomaterials 2009, 30:1928–1936.
Sadauskas, E, Danscher, G, Stoltenberg, M, Vogel, U, Larsen, A, Wallin, H. Protracted elimination of gold nanoparticles from mouse liver. Nanomedicine 2009, 5:162–169.
Terentyuk, GS, Maslyakova, GN, Suleymanova, LV, Khlebtsov, BN, Kogan, BY, Akchurin, GG, Shantrocha, AV, Maksimova, IL, Khlebtsov, NG, Tuchin, VV. Circulation and distribution of gold nanoparticles and induced alterations of tissue morphology at intravenous particle delivery. J Biophotonics 2009, 2:292–302.
Cho, WS, Cho, M, Jeong, J, Choi, M, Cho, HY, Han, BS, Kim, SH, Kim, HO, Lim, YT, Chung, BH, et al. Acute toxicity and pharmacokinetics of 13 nm‐sized PEG‐coated gold nanoparticles. Toxicol Appl Pharmacol 2009, 236:16–24.
Cho, WS, Cho, M, Jeong, J, Choi, M, Han, BS, Shin, HS, Hong, J, Chung, BH, Jeong, J, Cho, MH. Size‐dependent tissue kinetics of PEG‐coated gold nanoparticles. Toxicol Appl Pharmacol 2010, 245:116–123.
Libutti, SK, Paciotti, GF, Byrnes, AA, Alexander, HR Jr, Gannon, WE, Walker, M, Seidel, GD, Yuldasheva, N, Tamarkin, L. Phase I and pharmacokinetic studies of CYT‐6091, a novel PEGylated colloidal gold‐rhTNF nanomedicine. Clin Cancer Res 2010, 16:6139–6149.
Lankveld, DP, Rayavarapu, RG, Krystek, P, Oomen, AG, Verharen, HW, van Leeuwen, TG, De Jong, WH, Manohar, S. Blood clearance and tissue distribution of PEGylated and non‐PEGylated gold nanorods after intravenous administration in rats. Nanomedicine (Lond) 2011, 6:339–349.
Glazer, ES, Zhu, C, Hamir, AN, Borne, A, Thompson, CS, Curley, SA. Biodistribution and acute toxicity of naked gold nanoparticles in a rabbit hepatic tumor model. Nanotoxicology 2011, 5:459–468.
Zhou, C, Long, M, Qin, Y, Sun, X, Zheng, J. Luminescent gold nanoparticles with efficient renal clearance. Angew Chem Int Ed Engl 2011, 50:3168–3172.
Arvizo, RR, Miranda, OR, Moyano, DF, Walden, CA, Giri, K, Bhattacharya, R, Robertson, JD, Rotello, VM, Reid, JM, Mukherjee, P. Modulating pharmacokinetics, tumor uptake and biodistribution by engineered nanoparticles. PLoS One 2011, 6:e24374.
Mager, DE, Mody, V, Xu, C, Forrest, A, Lesniak, WG, Nigavekar, SS, Kariapper, MT, Minc, L, Khan, MK, Balogh, LP. Physiologically based pharmacokinetic model for composite nanodevices: effect of charge and size on in vivo disposition. Pharm Res 2012, 29:2534–2542.
Morais, T, Soares, ME, Duarte, JA, Soares, L, Maia, S, Gomes, P, Pereira, E, Fraga, S, Carmo, H, Bastos, ML. Effect of surface coating on the biodistribution profile of gold nanoparticles in the rat. Eur J Pharm Biopharm 2012, 80:185–193.
Chou, LY, Chan, WC. Fluorescence‐tagged gold nanoparticles for rapidly characterizing the size‐dependent biodistribution in tumor models. Adv Healthc Mater 2012, 1:714–721.
Almeida, JP, Lin, AY, Langsner, RJ, Eckels, P, Foster, AE, Drezek, RA. In vivo immune cell distribution of gold nanoparticles in naive and tumor bearing mice. Small 2013.
Wong, OA, Hansen, RJ, Ni, TW, Heinecke, CL, Compel, WS, Gustafson, DL, Ackerson, CJ. Structure‐activity relationships for biodistribution, pharmacokinetics, and excretion of atomically precise nanoclusters in a murine model. Nanoscale 2013, 5:10525–10533.
El‐Sayed, MA, Shabaka, AA, El‐Shabrawy, OA, Yassin, NA, Mahmoud, SS, El‐Shenawy, SM, Al‐Ashqar, E, Eisa, WH, Farag, NM, El‐Shaer, MA, et al. Tissue distribution and efficacy of gold nanorods coupled with laser induced photoplasmonic therapy in ehrlich carcinoma solid tumor model. PLoS One 2013, 8:e76207.
Alric, C, Miladi, I, Kryza, D, Taleb, J, Lux, F, Bazzi, R, Billotey, C, Janier, M, Perriat, P, Roux, S, et al. The biodistribution of gold nanoparticles designed for renal clearance. Nanoscale 2013, 5:5930–5939.
Kreyling, WG, Hirn, S, Moller, W, Schleh, C, Wenk, A, Celik, G, Lipka, J, Schaffler, M, Haberl, N, Johnston, BD, et al. Air‐blood barrier translocation of tracheally instilled gold nanoparticles inversely depends on particle size. ACS Nano 2014, 8:222–233.
Takenaka, S, Karg, E, Roth, C, Schulz, H, Ziesenis, A, Heinzmann, U, Schramel, P, Heyder, J. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect 2001, 109(Suppl 4):547–551.
Tang, J, Xiong, L, Wang, S, Wang, J, Liu, L, Li, J, Wan, Z, Xi, T. Influence of silver nanoparticles on neurons and blood‐brain barrier via subcutaneous injection in rats. Appl Surf Sci 2008, 255:502–504.
Garza‐Ocanas, L, Ferrer, DA, Burt, J, Diaz‐Torres, LA, Ramirez Cabrera, M, Rodriguez, VT, Lujan Rangel, R, Romanovicz, D, Jose‐Yacaman, M. Biodistribution and long‐term fate of silver nanoparticles functionalized with bovine serum albumin in rats. Metallomics 2010, 2:204–210.
Lankveld, DP, Oomen, AG, Krystek, P, Neigh, A, Troost‐de Jong, A, Noorlander, CW, Van Eijkeren, JC, Geertsma, RE, De Jong, WH. The kinetics of the tissue distribution of silver nanoparticles of different sizes. Biomaterials 2010, 31:8350–8361.
Park, K, Park, EJ, Chun, IK, Choi, K, Lee, SH, Yoon, J, Lee, BC. Bioavailability and toxicokinetics of citrate‐coated silver nanoparticles in rats. Arch Pharm Res 2011, 34:153–158.
van der Zande, M, Vandebriel, RJ, Van Doren, E, Kramer, E, Herrera Rivera, Z, Serrano‐Rojero, CS, Gremmer, ER, Mast, J, Peters, RJ, Hollman, PC, et al. Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28‐day oral exposure. ACS Nano 2012, 6:7427–7442.
Dziendzikowska, K, Gromadzka‐Ostrowska, J, Lankoff, A, Oczkowski, M, Krawczynska, A, Chwastowska, J, Sadowska‐Bratek, M, Chajduk, E, Wojewodzka, M, Dusinska, M, et al. Time‐dependent biodistribution and excretion of silver nanoparticles in male Wistar rats. J Appl Toxicol 2012, 32:920–928.
Xue, Y, Zhang, S, Huang, Y, Zhang, T, Liu, X, Hu, Y, Zhang, Z, Tang, M. Acute toxic effects and gender‐related biokinetics of silver nanoparticles following an intravenous injection in mice. J Appl Toxicol 2012, 32:890–899.
Lee, Y, Kim, P, Yoon, J, Lee, B, Choi, K, Kil, KH, Park, K. Serum kinetics, distribution and excretion of silver in rabbits following 28 days after a single intravenous injection of silver nanoparticles. Nanotoxicology 2013, 7:1120–1130.
Johnston, HJ, Hutchison, G, Christensen, FM, Peters, S, Hankin, S, Stone, V. A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol 2010, 40:328–346.
Bourrinet, P, Bengele, HH, Bonnemain, B, Dencausse, A, Idee, JM, Jacobs, PM, Lewis, JM. Preclinical safety and pharmacokinetic profile of ferumoxtran‐10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent. Invest Radiol 2006, 41:313–324.
Ma, HL, Xu, YF, Qi, XR, Maitani, Y, Nagai, T. Superparamagnetic iron oxide nanoparticles stabilized by alginate: pharmacokinetics, tissue distribution, and applications in detecting liver cancers. Int J Pharm 2008, 354:217–226.
Lee, MJ, Veiseh, O, Bhattarai, N, Sun, C, Hansen, SJ, Ditzler, S, Knoblaugh, S, Lee, D, Ellenbogen, R, Zhang, M, et al. Rapid pharmacokinetic and biodistribution studies using cholorotoxin‐conjugated iron oxide nanoparticles: a novel non‐radioactive method. PLoS One 2010, 5:e9536.
Xie, G, Wang, C, Sun, J, Zhong, G. Tissue distribution and excretion of intravenously administered titanium dioxide nanoparticles. Toxicol Lett 2011, 205:55–61.
Cole, AJ, David, AE, Wang, J, Galban, CJ, Yang, VC. Magnetic brain tumor targeting and biodistribution of long‐circulating PEG‐modified, cross‐linked starch‐coated iron oxide nanoparticles. Biomaterials 2011, 32:6291–6301.
Cole, AJ, David, AE, Wang, J, Galban, CJ, Hill, HL, Yang, VC. Polyethylene glycol modified, cross‐linked starch‐coated iron oxide nanoparticles for enhanced magnetic tumor targeting. Biomaterials 2011, 32:2183–2193.
Li, CH, Shen, CC, Cheng, YW, Huang, SH, Wu, CC, Kao, CC, Liao, JW, Kang, JJ. Organ biodistribution, clearance, and genotoxicity of orally administered zinc oxide nanoparticles in mice. Nanotoxicology 2012, 6:746–756.
Zhang, J, Shin, MC, David, AE, Zhou, J, Lee, K, He, H, Yang, VC. Long‐circulating heparin‐functionalized magnetic nanoparticles for potential application as a protein drug delivery platform. Mol Pharm 2013, 10:3892–3902.
Zhang, J, Li, B, Zhang, Y, Li, A, Yu, X, Huang, Q, Fan, C, Cai, X. Synchrotron radiation X‐ray fluorescence analysis of biodistribution and pulmonary toxicity of nanoscale titanium dioxide in mice. Analyst 2013, 138:6511–6516.
Landsiedel, R, Fabian, E, Ma‐Hock, L, van Ravenzwaay, B, Wohlleben, W, Wiench, K, Oesch, F. Toxico‐/biokinetics of nanomaterials. Arch Toxicol 2012, 86:1021–1060.
Almeida, JP, Chen, AL, Foster, A, Drezek, R. In vivo biodistribution of nanoparticles. Nanomedicine (Lond) 2011, 6:815–835.
Moss, DM, Siccardi, M. Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling. Br J Pharmacol 2014, 171:3963–3979.
Li, M, Al‐Jamal, KT, Kostarelos, K, Reineke, J. Physiologically based pharmacokinetic modeling of nanoparticles. ACS Nano 2010, 4:6303–6317.
Lin, Z, Fisher, JW, Wang, R, Ross, MK, Filipov, NM. Estimation of placental and lactational transfer and tissue distribution of atrazine and its main metabolites in rodent dams, fetuses, and neonates with physiologically based pharmacokinetic modeling. Toxicol Appl Pharmacol 2013, 273:140–158.
Jones, HM, Mayawala, K, Poulin, P. Dose selection based on physiologically based pharmacokinetic (PBPK) approaches. AAPS J 2013, 15:377–387.
Lipscomb, JC, Haddad, S, Poet, T, Krishnan, K. Physiologically‐based pharmacokinetic (PBPK) models in toxicity testing and risk assessment. Adv Exp Med Biol 2012, 745:76–95.
Buur, J, Baynes, R, Smith, G, Riviere, J. Use of probabilistic modeling within a physiologically based pharmacokinetic model to predict sulfamethazine residue withdrawal times in edible tissues in swine. Antimicrob Agents Chemother 2006, 50:2344–2351.
Bachler, G, von Goetz, N, Hungerbuhler, K. A physiologically based pharmacokinetic model for ionic silver and silver nanoparticles. Int J Nanomedicine 2013, 8:3365–3382.
Bachler, G, von Goetz, N, Hungerbuhler, K. Using physiologically based pharmacokinetic (PBPK) modeling for dietary risk assessment of titanium dioxide (TiO) nanoparticles. Nanotoxicology 2014:1–8.
Meng, X, Qiang, L, Wei, J. An overview on the pharmacokinetics of quantum dots. Curr Drug Metab 2013, 14:820–831.
Sonavane, G, Tomoda, K, Makino, K. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf B Biointerfaces 2008, 66:274–280.
Semmler‐Behnke, M, Kreyling, WG, Lipka, J, Fertsch, S, Wenk, A, Takenaka, S, Schmid, G, Brandau, W. Biodistribution of 1.4‐ and 18‐nm gold particles in rats. Small 2008, 4:2108–2111.
De Jong, WH, Hagens, WI, Krystek, P, Burger, MC, Sips, AJ, Geertsma, RE. Particle size‐dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 2008, 29:1912–1919.
Schleh, C, Holzwarth, U, Hirn, S, Wenk, A, Simonelli, F, Schaffler, M, Moller, W, Gibson, N, Kreyling, WG. Biodistribution of inhaled gold nanoparticles in mice and the influence of surfactant protein D. J Aerosol Med Pulm Drug Deliv 2013, 26:24–30.
Lipka, J, Semmler‐Behnke, M, Sperling, RA, Wenk, A, Takenaka, S, Schleh, C, Kissel, T, Parak, WJ, Kreyling, WG. Biodistribution of PEG‐modified gold nanoparticles following intratracheal instillation and intravenous injection. Biomaterials 2010, 31:6574–6581.
Balasubramanian, SK, Poh, KW, Ong, CN, Kreyling, WG, Ong, WY, Yu, LE. The effect of primary particle size on biodistribution of inhaled gold nano‐agglomerates. Biomaterials 2013, 34:5439–5452.
Sadauskas, E, Jacobsen, NR, Danscher, G, Stoltenberg, M, Vogel, U, Larsen, A, Kreyling, W, Wallin, H. Biodistribution of gold nanoparticles in mouse lung following intratracheal instillation. Chem Cent J 2009, 3:16.
Hussain, S, Vanoirbeek, JA, Haenen, S, Haufroid, V, Boland, S, Marano, F, Nemery, B, Hoet, PH. Prior lung inflammation impacts on body distribution of gold nanoparticles. Biomed Res Int 2013, 2013:923475.
Schleh, C, Semmler‐Behnke, M, Lipka, J, Wenk, A, Hirn, S, Schaffler, M, Schmid, G, Simon, U, Kreyling, WG. Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration. Nanotoxicology 2012, 6:36–46.
Hillyer, JF, Albrecht, RM. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J Pharm Sci 2001, 90:1927–1936.
Smith, CA, Simpson, CA, Kim, G, Carter, CJ, Feldheim, DL. Gastrointestinal bioavailability of 2.0 nm diameter gold nanoparticles. ACS Nano 2013, 7:3991–3996.
Monteiro‐Riviere, NA. Safety implications of nanomaterial exposure to skin. In: Monteiro‐Riviere, NA, Tran, CL, eds. Nanotoxicology: Progress Toward Nanomedicine. Boca Raton, FL: CRC Press; 2014 Chapter 22, 405–421.
Filon, FL, Crosera, M, Adami, G, Bovenzi, M, Rossi, F, Maina, G. Human skin penetration of gold nanoparticles through intact and damaged skin. Nanotoxicology 2011, 5:493–501.
Sonavane, G, Tomoda, K, Sano, A, Ohshima, H, Terada, H, Makino, K. In vitro permeation of gold nanoparticles through rat skin and rat intestine: effect of particle size. Colloids Surf B Biointerfaces 2008, 65:1–10.
Labouta, HI, Liu, DC, Lin, LL, Butler, MK, Grice, JE, Raphael, AP, Kraus, T, El‐Khordagui, LK, Soyer, HP, Roberts, MS, et al. Gold nanoparticle penetration and reduced metabolism in human skin by toluene. Pharm Res 2011, 28:2931–2944.
Lasagna‐Reeves, C, Gonzalez‐Romero, D, Barria, MA, Olmedo, I, Clos, A, Sadagopa Ramanujam, VM, Urayama, A, Vergara, L, Kogan, MJ, Soto, C. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem Biophys Res Commun 2010, 393:649–655.
Hawkins, BT, Davis, TP. The blood‐brain barrier/neurovascular unit in health and disease. Pharmacol Rev 2005, 57:173–185.
Frigell, J, Garcia, I, Gomez‐Vallejo, V, Llop, J, Penades, S. 68Ga‐labeled gold glyconanoparticles for exploring blood‐brain barrier permeability: preparation, biodistribution studies, and improved brain uptake via neuropeptide conjugation. J Am Chem Soc 2014, 136:449–457.
Kim, JH, Kim, JH, Kim, KW, Kim, MH, Yu, YS. Intravenously administered gold nanoparticles pass through the blood‐retinal barrier depending on the particle size, and induce no retinal toxicity. Nanotechnology 2009, 20:505101.
Perrault, SD, Walkey, C, Jennings, T, Fischer, HC, Chan, WC. Mediating tumor targeting efficiency of nanoparticles through design. Nano Lett 2009, 9:1909–1915.
Lo, CL, Chou, MH, Lu, PL, Lo, IW, Chiang, YT, Hung, SY, Yang, CY, Lin, SY, Wey, SP, Lo, JM, et al. The effect of PEG‐5 K grafting level and particle size on tumor accumulation and cellular uptake. Int J Pharm 2013, 456:424–431.
Huang, XL, Zhang, B, Ren, L, Ye, SF, Sun, LP, Zhang, QQ, Tan, MC, Chow, GM. In vivo toxic studies and biodistribution of near infrared sensitive Au‐Au(2)S nanoparticles as potential drug delivery carriers. J Mater Sci Mater Med 2008, 19:2581–2588.
Yang, H, Sun, C, Fan, Z, Tian, X, Yan, L, Du, L, Liu, Y, Chen, C, Liang, XJ, Anderson, GJ, et al. Effects of gestational age and surface modification on materno‐fetal transfer of nanoparticles in murine pregnancy. Sci Rep 2012, 2:847.
Keene, AM, Peters, D, Rouse, R, Stewart, S, Rosen, ET, Tyner, KM. Tissue and cellular distribution of gold nanoparticles varies based on aggregation/agglomeration status. Nanomedicine (Lond) 2012, 7:199–209.
Romberg, B, Hennink, WE, Storm, G. Sheddable coatings for long‐circulating nanoparticles. Pharm Res 2008, 25:55–71.
See, V, Free, P, Cesbron, Y, Nativo, P, Shaheen, U, Rigden, DJ, Spiller, DG, Fernig, DG, White, MR, Prior, IA, et al. Cathepsin L digestion of nanobioconjugates upon endocytosis. ACS Nano 2009, 3:2461–2468.
Zhang, XD, Wu, D, Shen, X, Liu, PX, Fan, FY, Fan, SJ. In vivo renal clearance, biodistribution, toxicity of gold nanoclusters. Biomaterials 2012, 33:4628–4638.
Hirn, S, Semmler‐Behnke, M, Schleh, C, Wenk, A, Lipka, J, Schaffler, M, Takenaka, S, Moller, W, Schmid, G, Simon, U, et al. Particle size‐dependent and surface charge‐dependent biodistribution of gold nanoparticles after intravenous administration. Eur J Pharm Biopharm 2011, 77:407–416.
Kempson, IM, Chien, CC, Chung, CY, Hwu, Y, Paterson, D, de Jonge, MD, Howard, DL. Fate of intravenously administered gold nanoparticles in hair follicles: follicular delivery, pharmacokinetic interpretation, and excretion. Adv Healthc Mater 2012, 1:736–741.
Li, D, Johanson, G, Emond, C, Carlander, U, Philbert, M, Jolliet, O. Physiologically based pharmacokinetic modeling of polyethylene glycol‐coated polyacrylamide nanoparticles in rats. Nanotoxicology 2014, 8:128–137.
Lee, HA, Leavens, TL, Mason, SE, Monteiro‐Riviere, NA, Riviere, JE. Comparison of quantum dot biodistribution with a blood‐flow‐limited physiologically based pharmacokinetic model. Nano Lett 2009, 9:794–799.
Sahneh, FD, Scoglio, CM, Monteiro‐Riviere, NA, Riviere, JE. Predicting the impact of biocorona formation kinetics on interspecies extrapolations of nanoparticle biodistribution modeling. Nanomedicine (Lond) 2014:1–9.
Riviere, JE. Of mice, men and nanoparticle biocoronas: are in vitro to in vivo correlations and interspecies extrapolations realistic? Nanomedicine (Lond) 2013, 8:1357–1359.
Samberg, ME, Oldenburg, SJ, Monteiro‐Riviere, NA. Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro. Environ Health Perspect 2010, 118:407–413.
Larese, FF, D`Agostin, F, Crosera, M, Adami, G, Renzi, N, Bovenzi, M, Maina, G. Human skin penetration of silver nanoparticles through intact and damaged skin. Toxicology 2009, 255:33–37.
Loeschner, K, Hadrup, N, Qvortrup, K, Larsen, A, Gao, X, Vogel, U, Mortensen, A, Lam, HR, Larsen, EH. Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Part Fibre Toxicol 2011, 8:18.
Park, EJ, Bae, E, Yi, J, Kim, Y, Choi, K, Lee, SH, Yoon, J, Lee, BC, Park, K. Repeated‐dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles. Environ Toxicol Pharmacol 2010, 30:162–168.
Kim, YS, Song, MY, Park, JD, Song, KS, Ryu, HR, Chung, YH, Chang, HK, Lee, JH, Oh, KH, Kelman, BJ, et al. Subchronic oral toxicity of silver nanoparticles. Part Fibre Toxicol 2010, 7:20.
Kim, YS, Kim, JS, Cho, HS, Rha, DS, Kim, JM, Park, JD, Choi, BS, Lim, R, Chang, HK, Chung, YH, et al. Twenty‐eight‐day oral toxicity, genotoxicity, and gender‐related tissue distribution of silver nanoparticles in Sprague‐Dawley rats. Inhal Toxicol 2008, 20:575–583.
Gaiser, BK, Hirn, S, Kermanizadeh, A, Kanase, N, Fytianos, K, Wenk, A, Haberl, N, Brunelli, A, Kreyling, WG, Stone, V. Effects of silver nanoparticles on the liver and hepatocytes in vitro. Toxicol Sci 2013, 131:537–547.
Kim, WY, Kim, J, Park, JD, Ryu, HY, Yu, IJ. Histological study of gender differences in accumulation of silver nanoparticles in kidneys of Fischer 344 rats. J Toxicol Environ Health A 2009, 72:1279–1284.
Genter, MB, Newman, NC, Shertzer, HG, Ali, SF, Bolon, B. Distribution and systemic effects of intranasally administered 25 nm silver nanoparticles in adult mice. Toxicol Pathol 2012, 40:1004–1013.
Ji, JH, Jung, JH, Kim, SS, Yoon, JU, Park, JD, Choi, BS, Chung, YH, Kwon, IH, Jeong, J, Han, BS, et al. Twenty‐eight‐day inhalation toxicity study of silver nanoparticles in Sprague‐Dawley rats. Inhal Toxicol 2007, 19:857–871.
Kreuter, J, Alyautdin, RN, Kharkevich, DA, Ivanov, AA. Passage of peptides through the blood‐brain barrier with colloidal polymer particles (nanoparticles). Brain Res 1995, 674:171–174.
Liu, J, Wang, Z, Liu, FD, Kane, AB, Hurt, RH. Chemical transformations of nanosilver in biological environments. ACS Nano 2012, 6:9887–9899.
Leavens, TL, Monteiro‐Riviere, NA, Inman, AO, Brooks, JD, Oldenburg, SJ, Riviere, JE. In vitro biodistribution of silver nanoparticles in isolated perfused porcine skin flaps. J Appl Toxicol 2012, 32:913–919.
Riviere, JE. Pharmacokinetics and biodistribution of nanomaterials. In: Monteiro‐Riviere, NA, Tran, CL, eds. Nanotoxicology: Progress Toward Nanomedicine. 2nd ed. Boca Raton, FL: Taylor %26 Francis Group; 2014, 135–152.
Janer, G, Molino, EM, Fernandez‐Rosas, E, Fernandez, A, Vazquez‐Campos, S. Cell uptake and oral absorption of titanium dioxide nanoparticles. Toxicol Lett 2014, 228:103–110.
Wang, J, Zhou, G, Chen, C, Yu, H, Wang, T, Ma, Y, Jia, G, Gao, Y, Li, B, Sun, J, et al. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol Lett 2007, 168:176–185.
Yamashita, K, Yoshioka, Y, Higashisaka, K, Mimura, K, Morishita, Y, Nozaki, M, Yoshida, T, Ogura, T, Nabeshi, H, Nagano, K, et al. Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nat Nanotechnol 2011, 6:321–328.
Takeda, K, Suzuki, K‐I, Ishihara, A, Kubo‐Irie, M, Fujimoto, R, Tabata, M, Oshio, S, Nihei, Y, Ihara, T, Sugamata, M. Nanoparticles transferred from pregnant mice to their offspring can damage the genital and cranial nerve systems. J Health Sci 2009, 55:95–102.
Monteiro‐Riviere, NA, Inman, AO, Ryman‐Rasmussen, JP. Dermal effects of nanomaterials. In: Monteiro‐Riviere, NA, Tran, CL, eds. Nanotoxicology: Characterization, Dosing, and Health Effects. New York: Informa Healthcare; 2007, 317–338.
Monteiro‐Riviere, NA, Baroli, B. Nanomaterial penetration. In: Monteiro‐Riviere, NA, ed. Toxicology of the Skin‐Target Organ Series. New York: Informa Healthcare; 2010, 333–346.
Monteiro‐Riviere, NA, Riviere, JE. Interaction of nanomaterials with skin: aspects of absorption and biodistribution. Nanotoxicology 2009, 3:188–193.
Riviere, JE, Scoglio, C, Sahneh, FD, Monteiro‐Riviere, NA. Computational approaches and metrics required for formulating biologically realistic nanomaterial pharmacokinetic models. Comput Sci Discov 2013, 6:014005.